In The News

Q&A on the Overdose Crisis

By the National Institute for Health Care Management

The CDC estimates that more than 107,000 Americans died of drug overdoses last year - a record high. Learn more about the overdose crisis:

Q: How are racial disparities widening in overdose deaths?
A: According to a CDC report, overdose deaths are increasing fast among Black and Indigenous people. Black people ages 15 to 24 had an 86% increase in death rates compared to a 34% increase among White people of the same age group. The disproportionate increase among Black and Indigenous people may be due to health inequities, like unequal access to treatment.

Q: What is the role of fentanyl in the overdose crisis?
A: 
Deaths involving illicitly manufactured fentanyl are on the rise, which is often mixed with other illicit drugs without the user’s knowledge. Fentanyl-related deaths in the U.S. occur more often than gun and auto-related deaths combined. The Drug Enforcement Agency warns of a nationwide spike in fentanyl-related mass-overdose events. 

Q: How does harm reduction reduce overdose deaths?
A:
 The Biden administration’s strategy to address the overdose crisis is the first to incorporate harm reduction strategies, which include access to naloxone (the antidote to opioid overdoses), sterile needles, drug test strips, and supervised injection sites. 

Q: Are people with addiction able to receive treatment?
A:
 A recent study found that 87% of people with opioid use disorder (OUD) do not receive evidence-based treatment. Medications for OUD can reduce opioid overdoses by 50%.

Q: What about people with chronic pain?
A:
 The 2016 CDC guidelines for prescribing opioids for pain have been credited with leading to harmful consequences for patients with chronic pain. The 2022 proposed guidelines remove the upper limits for prescription opioids, emphasize a patient-centric approach, and expand on alternative treatments.

Resources & Initiatives:

SAMHSA’s National Helpline for individuals and families facing mental and/or substance use disorders is 1-800-662-HELP.

 

CMS Hospice Quality Reporting Programs Updates

From NHPCO

On August 4, 2022 CMS announced the following updates that go into effect with this month’s HQRP data refresh.

  • Hospice Visits in the Last Days of Life (HVLDL): On July 26, 2022, the National Quality Forum (NQF) endorsed the claims-based measure, Hospice Visits in the Last Days of Life, or HVLDL as NQF #3645. According to CMS “HVLDL reflects the proportion of hospice patients who received in-person visits from a registered nurse or a medical social worker on at least two of the final three days of life. HVLDL is the re-specified measure replacing the HIS-based Hospice Visits When Death is Imminent (HVWDII).” The August 2022 refresh will be the inaugural month for public reporting for HVLDL, which replaces public reporting of HVWDII. Further information, including a link to the NQF website, can be found on the Hospice Quality Reporting Program (HQRP) Quality Measure Development webpage.

  • Public Display of Hospice Care Index (HCI): Public reporting will also be available for the HCI measure during the August 2022 HQRP data refresh. The HCI is a single Medicare claims-based measure that includes 10 indicators of hospice stay, including indicators like burdensome transition and visits near the end of life. The HCI Technical Report has been made available for download effective July 1, 2022.

  • Consumer Assessment of Healthcare Providers and Systems (CAHPS) Hospice Star Ratings: CMS is targeting the August 2022 refresh for inaugural public reporting of the new Family Caregiver Survey Rating Summary Star Rating for the CAHPS Hospice Survey measure scores. Beginning this month, it will be publicly reported for all hospices with 75 or more completed surveys over the reporting period. Star Ratings will be updated every other quarter (every six months). Prior to public reporting, CAHPS Hospice Survey results are adjusted for effects of mode of survey administration and case mix. Details with overview of the purpose, timeline and methods can be found on the website. The national and state Star Rating distribution reports for the most recent reporting periods are available for download.

Additionally, CMS shared two new videos with helpful explanations on HQRP and HCI:

For questions, email [email protected].

 

Impact of Proposed Home Health Rule is Significant

The attached Dobson and Davanzo table includes the impacts of the 7.69%, the impact of the “clawback” of the temporary adjustments (for the 2020-2021 data and then an estimate of the impact of the 2022 clawback) for all 50 states.

The Partnership for Medicaid Home-Based Care will be creating state one pagers with this data – demonstrating the impact on each state. Stay tuned. HHAC will circulate the one-pages once they are finalized.

Please urge Congress to sign onto the Preserving Access to Home Health Act (S.B. 4605) that has been introduced into both the Senate and the House. The bill would freeze the current payment rate in place, with the exception of annual market basket updates, through 2025. 

Calls and personal messages are best, but for those short on time a message has been pre-drafted and is ready to go in the NAHC Virtual Advocacy Center.  

 

Monkeypox a Federal Public Health Emergency

Last Thursday, 08/04/2022, the Biden administration declared a federal public health emergency (PHE) for monkeypox.

During a call with reporters, HHS Secretary Xavier Becerra said that some 6,600 cases of the virus had already been reported for the week compared to less than 5,000 the week before.

The virus has spread primarily through close contact with someone who is infected. Treatment includes isolation and pain management, often at home. It is rarely fatal.

Designating the outbreak as a PHE allows federal agencies to access emergency funding and allocate funds and other resources to help prevent the spread of the virus. Such declarations also permit the waiver of some laws and requirements to allow healthcare providers to respond to the disease.

On July 23 the World Health Organization (WHO) declared a global health emergency over the outbreak.

 

With Choose Home Up In the Air, Providers Consider Preparation Strategies

Home Health Care News | By Andrew Donlan
 
The home health industry at large is excited about the prospects of the Choose Home Care Act of 2021.
 
For now, it’s been tabled in Washington, D.C., due to a variety of reasons, including it being an election year. It’s also – to some extent – been cast aside in home providers’ minds, given all the mayhem going on related to the Centers for Medicare & Medicaid Services’ (CMS) proposed rule for 2023.
 
If the Choose Home legislation does come to fruition, it could be a massive tailwind for providers. The catch is that not all providers will benefit.
 
Instead, the ones that will benefit will be the ones that become designated Choose Home agencies. And in order to become that, they’ll likely need to begin prepping now for a bill that could come through as early next year, or never come to fruition at all.
 
“If this sounds good to you, what you should be working on now is to prepare yourself so that you can become a designated Choose Home agency,” Deborah Hoyt, senior vice president of public policy for Axxess, said last week at the National Association for Home Care & Hospice’s (NAHC) Financial Management Conference.
 
Dallas-based Axxess is technology company that develops cloud-based software solutions for home health, home care and hospice agencies across the country.
 
Broadly, Choose Home would allow for more skilled nursing facility (SNF) diversion in post-acute care, allowing home health agencies – utilizing an add-on to their existing home health benefit – to care for more higher-acuity patients in the home.
 
“Though it’s not yet enacted, there’s a lot of things that you can start doing today to help your organization prepare questions that you need to be asking,” Maria Warren, the VP of clinical consulting at McBee Associates, also said at FMC. “In approaching anything, whether it be Choose Home, a hospital-at-home program, diversifying services or implementing new technology, you want to take everything into a strategic assessment.”
 
That strategic assessment should include five steps, Warren said:

  • Establish governance, strategy team and pilot team.

  • Outline the current state of the agency, collecting as much data as possible, as well a GAP analysis

  • Conduct external assessment – analyzing competitors, the market and other findings. This step should also include considering partnerships as well as other M&A opportunities.

  • Act on data: “Look to integrative technologies and AI to better align staff to your patient population needs. Use predictive analytics to identify patient needs and prioritize patient visits.”

  • Continuously measure and monitor; the final step is to use data to drive action and accountability internally and externally to get desired results

To prepare or not
 
The steps to preparing for Choose Home raise another question for every home health agency: ‘Is this worth my time?’. . .
 
Read Full Article

 
<< first < Prev 171 172 173 174 175 176 177 178 179 180 Next > last >>

Page 180 of 357